Artificial Intelligence and Circulating Cell-Free DNA Methylation Profiling: Mechanism and Detection of Alzheimer’s Disease
Authors:
- Ray O. Bahado-SinghRay O. Bahado-Singh
- Uppala RadhakrishnaURUppala Radhakrishna
- Juozas GordevičiusJGJuozas Gordevičius
- Buket AydasBABuket Aydas
- Ali YilmazAli Yilmaz
- Faryal JafarFJFaryal Jafar
- Khaled ImamKIKhaled Imam
- Michael MaddensMMMichael Maddens
- Kshetra ChallapalliKCKshetra Challapalli
- Raghu P. MetpallyRMRaghu P. Metpally
- Wade H. BerrettiniWBWade H. Berrettini
- Richard C. CristRCRichard C. Crist
Open Access
Abstract
Background: Despite extensive efforts, significant gaps remain in our understanding of Alzheimer’s disease (AD) pathophysiology. Novel approaches using circulating cell-free DNA (cfDNA) have the potential to revolutionize our understanding of neurodegenerative disorders. Methods: We performed DNA methylation profiling of cfDNA from AD patients and compared them to cognitively normal controls. Six Artificial Intelligence (AI) platforms were utilized for the diagnosis of AD while enrichment analysis was used to elucidate the pathogenesis of AD. Results: A total of 3684 CpGs were significantly (adj. p-value < 0.05) differentially methylated in AD versus controls. All six AI algorithms achieved high predictive accuracy (AUC = 0.949–0.998) in an independent test group. As an example, Deep Learning (DL) achieved an AUC (95% CI) = 0.99 (0.95–1.0), with 94.5% sensitivity and specificity. Conclusion: We describe numerous epigenetically altered genes which were previously reported to be differentially expressed in the brain of AD sufferers. Genes identified by AI to be the best predictors of AD were either known to be expressed in the brain or have been previously linked to AD. We highlight enrichment in the Calcium signaling pathway, Glutamatergic synapse, Hedgehog signaling pathway, Axon guidance and Olfactory transduction in AD sufferers. To the best of our knowledge, this is the first reported genome-wide DNA methylation study using cfDNA to detect AD.Keywords
Funding Information
- Beaumont Hospital and the Research Institute
- The John and Marilyn Bishop Charitable Foundation and from the Fred A. & Barbara M. Erb Foundation & Maibach family
This publication has 87 references indexed in Scilit:
- The Genotype-Tissue Expression (GTEx) projectNature Genetics, 2013
- Genes and pathways underlying regional and cell type changes in Alzheimer's diseaseGenome Medicine, 2013
- Protein Phosphatases and Alzheimer's Disease2012
- Multivariate methods in metabolomics – from pre-processing to dimension reduction and statistical analysisTrAC Trends in Analytical Chemistry, 2011
- Epigenetic ModificationsCirculation, 2011
- The role of CREB signaling in Alzheimer’s disease and other cognitive disordersReviews in the Neurosciences, 2011
- BMP signaling in vascular development and diseaseCytokine & Growth Factor Reviews, 2010
- Analysis of Metabolomic Data Using Support Vector MachinesAnalytical Chemistry, 2008
- Direct interaction of myosin regulatory light chain with the NMDA receptorJournal of Neurochemistry, 2004
- The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s DiseaseNeurosignals, 2002